NuCana PLC (NCNA)
3.61
-0.06
(-1.63%)
USD |
NASDAQ |
May 17, 16:00
3.61
0.00 (0.00%)
After-Hours: 20:00
NuCana 1 Year Total Returns (Daily): -80.43% for May 16, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 16, 2024 | -80.43% |
May 15, 2024 | -80.96% |
May 14, 2024 | -80.35% |
May 13, 2024 | -81.11% |
May 10, 2024 | -80.06% |
May 09, 2024 | -80.28% |
May 08, 2024 | -79.03% |
May 07, 2024 | -77.83% |
May 06, 2024 | -78.00% |
May 03, 2024 | -78.47% |
May 02, 2024 | -79.67% |
May 01, 2024 | -80.35% |
April 30, 2024 | -81.34% |
April 29, 2024 | -81.15% |
April 26, 2024 | -82.22% |
April 25, 2024 | -83.12% |
April 24, 2024 | -83.48% |
April 23, 2024 | -82.98% |
April 22, 2024 | -83.02% |
April 19, 2024 | -83.71% |
April 18, 2024 | -83.16% |
April 17, 2024 | -82.92% |
April 16, 2024 | -82.47% |
April 15, 2024 | -80.00% |
April 12, 2024 | -74.45% |
Date | Value |
---|---|
April 11, 2024 | -74.56% |
April 10, 2024 | -73.86% |
April 09, 2024 | -73.33% |
April 08, 2024 | -73.48% |
April 05, 2024 | -72.94% |
April 04, 2024 | -72.81% |
April 03, 2024 | -72.68% |
April 02, 2024 | -76.06% |
April 01, 2024 | -75.32% |
March 28, 2024 | -69.52% |
March 27, 2024 | -61.82% |
March 26, 2024 | -75.32% |
March 25, 2024 | -74.69% |
March 22, 2024 | -76.24% |
March 21, 2024 | -82.65% |
March 20, 2024 | -73.80% |
March 19, 2024 | -73.01% |
March 18, 2024 | -70.38% |
March 15, 2024 | -71.18% |
March 14, 2024 | -67.97% |
March 13, 2024 | -66.93% |
March 12, 2024 | -70.64% |
March 11, 2024 | -74.81% |
March 08, 2024 | -76.50% |
March 07, 2024 | -77.70% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-86.35%
Minimum
Mar 14 2022
91.26%
Maximum
Mar 08 2023
-46.64%
Average
-52.87%
Median
1 Year Total Returns (Daily) Benchmarks
Adaptimmune Therapeutics PLC | -8.40% |
Biodexa Pharmaceuticals Plc | -93.16% |
Autolus Therapeutics PLC | 64.78% |
Mereo BioPharma Group PLC | 184.3% |
Bicycle Therapeutics PLC | -7.20% |